Detalles de la búsqueda
1.
Propionibacterium freudenreichii CIRM-BIA 129 mitigates colitis through S layer protein B-dependent epithelial strengthening.
Am J Physiol Gastrointest Liver Physiol
; 326(2): G163-G175, 2024 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37988603
2.
Alterations of Prostanoid Expression and Intestinal Epithelial Barrier Functions in Ileus.
J Surg Res
; 296: 165-173, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38277953
3.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129136
4.
Evaluation of Scores to Reflect Toxicity Impact on Quality of Life of Patients With Platinum-Resistant Ovarian Cancer: AURELIA Substudy.
J Natl Compr Canc Netw
; 21(5): 473-479.e4, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156482
5.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183733
6.
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Anal Chem
; 94(16): 6297-6303, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416669
7.
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Gynecol Oncol
; 164(2): 254-264, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952708
8.
Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
Gynecol Oncol
; 164(1): 18-26, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34696892
9.
Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
Gynecol Oncol
; 166(3): 389-396, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902297
10.
Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
Gynecol Oncol
; 163(2): 274-280, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452745
11.
GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin.
Int J Mol Sci
; 21(22)2020 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33238628
12.
Non-pegylated liposomal doxorubicin (NPLD, Myocet®)â¯+â¯carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial.
Gynecol Oncol
; 152(1): 68-75, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446275
13.
Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.
Support Care Cancer
; 27(5): 1879-1889, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194492
14.
Effective treatment based on monitoring bESR1 mutations - Authors' reply.
Lancet Oncol
; 24(1): e4, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603926
15.
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 17(5): 600-11, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27032301
16.
Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study.
Cancer
; 122(20): 3119-3126, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27412268
17.
Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial.
Gynecol Oncol
; 136(1): 18-24, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25281492
18.
Association between endocrine adjuvant therapy intake timing and disease-free survival in patients with high-risk early breast cancer: results of a sub-study of the UCBG- UNIRAD trial.
EBioMedicine
; 104: 105141, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718683
19.
Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency.
Int J Cancer
; 133(3): 757-65, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23354868
20.
Region-specific remodeling of the enteric nervous system and enteroendocrine cells in the colon of spinal cord injury patients.
Sci Rep
; 13(1): 16902, 2023 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37803037